Long-Term Assets: The sum of all assets classified as non-current.
Emmaus Life Sciences, Inc. (EMMA) had Long-Term Assets of $13.69M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.85M |
|
$-1.95M |
|
$0.23M |
|
$3.62M |
|
$2.97M |
|
$0.89M |
|
$-2.82M |
|
$-1.94M |
|
$-1.94M |
|
$-1.95M |
|
$-1.95M |
|
$-1.95M |
|
$-2.13M |
|
$0.89M |
|
$1.09M |
|
64.04M |
|
64.04M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$7.75M |
|
$0.11M |
|
|
Long-Term Assets |
$13.69M |
$21.44M |
|
$69.07M |
|
$2.27M |
|
$15.97M |
|
$85.04M |
|
$-63.61M |
|
$-63.61M |
|
$-63.61M |
|
70.19M |
|
| Cash Flow Statement Financials | |
$-0.01M |
|
$2.17M |
|
$-1.43M |
|
$1.39M |
|
$2.13M |
|
$0.74M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.11 |
|
-- |
|
-- |
|
-0.04 |
|
-0.48 |
|
93.90% |
|
23.00% |
|
23.00% |
|
-- |
|
-50.23% |
|
-50.65% |
|
$-0.01M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.15 |
|
1.37 |
|
65.51 |
|
3.07% |
|
3.07% |
|
-9.10% |
|
3.18% |
|
$-0.91 |
|
$-0.00 |
|
$-0.00 |
|